[CYCC] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
01-Apr-2013
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY- 13.49%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Annual Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 1,944 1,734 1,084 69 699 686 911 13.45%
PBT -16,486 -22,649 -11,880 -15,107 -15,808 -16,678 -20,518 -3.57%
Tax -2,144 -3,243 -1,670 -1,351 -565 -657 -948 14.56%
NP -14,342 -19,387 -10,153 -13,186 -15,243 -16,021 -19,570 -5.04%
Tax Rate - - - - - - - -
Total Cost 16,286 21,121 11,237 13,255 15,942 16,707 20,481 -3.74%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -737.76 -1,118.05 -936.62 -19,110.14 -2,180.69 -2,335.42 -2,148.19 -16.30%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -105.72 -211.93 -160.75 -440.40 -509.10 -711.22 -1,481.23 -35.58%
EPS Diluted -105.72 -211.93 -160.75 -440.40 -509.10 -711.22 -1,481.23 -35.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.